Questcor Pharmaceuticals, Inc. (QCOR)

#dropmenudiv{ position:absolute; border:1px solid black; border-bottom-width: 0; font:normal 12px Verdana; line-height:18px; z-index:100; } #dropmenudiv a{ width: 100%; display: block; text-indent: 3px; border-bottom: 1px solid black; padding: 1px 0; text-decoration: none; font-weight: bold; } #dropmenudiv a:hover{ /*hover background color*/ background-color: black; } RockingStocks.com - Rocking Stocks - Stock Picks, Featured Profiles, Stock Updates, Stock Information, Intraday Stock Alerts, Daily Stock Analysis

Stock Picks, Featured Profiles, Stock Updates, Stock Information, Intraday Stock Alerts, Daily Stock Analysis

RockingStocks.com Stock Picks

Your browser does not support inline frames or is currently configured not to display inline frames.

February 18, 2009

Rockin' Stock Pick: Questcor Pharmaceuticals, Inc. (QCOR)

Stock Price: $7.27

Questcor Pharmaceuticals, Inc. is a pharmaceutical company that markets two commercial products, H.P. Acthar® Gel (``Acthar'') and Doral®. Acthar (repository corticotropin injection) is an injectable drug that is approved for the treatment of certain disorders with an inflammatory component. Doral is indicated for the treatment of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings.

QCOR will be reporting fourth quarter earnings on Tuesday, February 24th after the close. QCOR has grown revenue from $12.78 million in 2006 to $49.76 million in 2007 and has reported revenue of $68.23 million during the first three quarters of 2008.

QCOR has high profit margins built into their business. QCOR's net income over the last three quarters has come in at $24.29. QCOR is trading at a PE of only around 10 and has a market cap of less than $500 million.

QCOR has been in an uptrend since the beginning of February and could break out in the near future. Its chart is looking attractive with its 50-day moving average right above at $7.58.

Disclosure: RockingStocks.com is owned by SpeculatingStocks.com, Inc. SpeculatingStocks.com, Inc. is not a registered investment adviser or broker/dealer. SpeculatingStocks.com, Inc. makes no recommendation that the purchase of securities of companies profiled in this Web site are suitable or advisable for any person or that an investment in such securities will be profitable. Generally, given the nature of the companies profiled and the possible lack of liquidity for their securities, investing in such securities is highly speculative and carries a high degree of risk. Never invest based solely on information from this Web site or our email alerts.

DISCLAIMER & RISK DISCLOSURE: RockingStocks.com and SpeculatingStocks.com, Inc. and our affiliates ("our companies") are not registered investment advisers or broker/dealers. Our companies make no commitment that the purchase of securities of companies profiled or otherwise mentioned in our websites are suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the possible lack of liquidity for their securities, investing in such securities is highly speculative and carries a high degree of risk. Never invest based solely on information from this Web site or our email alerts. Our RockingStocks.com Newsletter is our free alert email membership. We profile selected companies on our site. These companies compensate SpeculatingStocks.com, Inc. for profile coverage. This compensation can be found in the disclosure on the bottom of the page of profiles. This Disclaimer & Risk Disclosure is also at the bottom of profiles. Specific questions on membership or profiles can be obtained by writing RockingStocks.com at: staff@rockingstocks.com.